Latest RGLS reports update at 2024-05-09: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Regulus Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Regulus Therapeutics logo
Regulus Therapeutics RGLS
$ 2.29 1.33%
mail-toReport an Error

Regulus Therapeutics EV/EBITDA Ratio 2011-2024 | RGLS

Annual EV/EBITDA Ratio Regulus Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.71 -1.62 0.0534 -0.243 -1.5 -0.928 -5.29 -19.7 -21.2 -1.62 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.71 -21.2 -5.03